PTGER4 and neoplasm: An exception to the general conclusions regarding the tumor-promoting role of EP4 is in gastric carcinoma cell lines where administration of EP2 and EP4 agonists resulted in growth inhibition, decreased cell proliferation, and was accompanied by cAMP production.